Literature DB >> 1078394

Familial and acquired type V hyperlipoproteinemia.

R W Fallat1, C J Glueck.   

Abstract

The nature of Type V hyperlipoproteinemia including mode of presentation, prominent clinical and biochemical features, and genetics, was examined in 29 adults presenting with the Type V lipoprotein phenotype. Initially 23 of the 29 patients had various metabolic stimuli (diabetes out of control, estrogenic agents, pancreatitis, ethanolism) superposed on their acute hypertriglyceridemia. After metabolic stabilization, 17 of the 29 subjects were shown to have familial hypertriglyceridemia. In the 17 kindreds with familial hypertriglyceridemia, the lack of a specific, distinctive genetic marker for the Type V genotype and for the Type IV genotype restricts the conclusion that the pattern of inheritance was consistent with an autosomal dominant trait.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1078394     DOI: 10.1016/0021-9150(76)90117-9

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  6 in total

1.  [Coronary heart disease in patients with primary type V hyperlipoproteinemia (author's transl)].

Authors:  G Middelhoff; R Mordasini; H Zebe; H Greten
Journal:  Klin Wochenschr       Date:  1978-05-01

2.  The effect of L-asparaginase on lipid metabolism during induction chemotherapy of childhood lymphoblastic leukaemia.

Authors:  P Cremer; M Lakomek; W Beck; G Prindull
Journal:  Eur J Pediatr       Date:  1988-01       Impact factor: 3.183

3.  CI-719 in hyperlipoproteinaemia: interim data.

Authors:  W F Bremner; J L Third; B Clark; C Corstorphine; T D Lawrie
Journal:  Proc R Soc Med       Date:  1976

4.  Diagnostic evaluation of acute pancreatitis in two patients with hypertriglyceridemia.

Authors:  Yoshifumi Okura; Kozo Hayashi; Tetsuji Shingu; Goro Kajiyama; Yoshiyuki Nakashima; Keijiro Saku
Journal:  World J Gastroenterol       Date:  2004-12-15       Impact factor: 5.742

5.  Type V hyperlipoproteinaemia in neonates.

Authors:  G N Thompson; A J Knight; I H Craig; J L Bresson
Journal:  Arch Dis Child       Date:  1987-09       Impact factor: 3.791

6.  Increased prevalence of apolipoprotein E4 in type V hyperlipoproteinemia.

Authors:  G Ghiselli; E J Schaefer; L A Zech; R E Gregg; H B Brewer
Journal:  J Clin Invest       Date:  1982-08       Impact factor: 14.808

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.